GlassScriptPhysician profile
Kurt David Vanwinkle
NPI 1295816007
$2,806.50
in general payments reported to CMS, 2019-2025
8 companies · $2,160 in 2025
The $2,160 reported for 2025 was more than what 92% of Periodontics providers received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.55 · 2020: $97.53 · 2021: $20.55 · 2022: $163 · 2023: $318 · 2025: $2,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $1,975 · Gift: $362 · Entertainment: $110 · Food and Beverage: $30.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $1,975.00 |
| Gift | $362.00 |
| Entertainment | $109.89 |
| Food and Beverage | $30.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $2,000.40 | 2022-2025 | Statim 2000 Cassette Autoclave |
| A-Dec, INC. | $362.00 | 2023-2025 | |
| Keystone Dental INC. | $167.60 | 2020-2025 | |
| Straumann USA LLC | $129.53 | 2022-2025 | |
| Septodont INC. | $72.93 | 2020 | |
| Nobel Biocare USA | $47.55 | 2019 | |
| Philips North America LLC | $13.34 | 2020 | |
| Geistlich Pharma, North America, INC. | $13.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Vanwinkle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.